However, the immunoreactivities of several related enzymes, including aromatase, which significantly contributes to intratumoral estrogen concentrations, were not associated with estradiol concentrations in nine breast cancers (Takagi et al. 2010). The gene discussed is CYP19A1; the disease is breast carcinoma.